Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) FCF Margin (2016 - 2025)

Medifast's FCF Margin history spans 16 years, with the latest figure at 8.83% for Q4 2025.

  • For Q4 2025, FCF Margin fell 275.0% year-over-year to 8.83%; the TTM value through Dec 2025 reached 0.32%, down 250.0%, while the annual FY2025 figure was 0.32%, 250.0% down from the prior year.
  • FCF Margin reached 8.83% in Q4 2025 per MED's latest filing, down from 12.02% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 17.83% in Q1 2021 to a low of 8.83% in Q4 2025.
  • Average FCF Margin over 5 years is 6.04%, with a median of 6.04% recorded in 2024.
  • Peak YoY movement for FCF Margin: tumbled -2264bps in 2021, then soared 1770bps in 2022.
  • A 5-year view of FCF Margin shows it stood at 5.05% in 2021, then surged by 351bps to 12.65% in 2022, then tumbled by -60bps to 5.01% in 2023, then plummeted by -221bps to 6.08% in 2024, then plummeted by -45bps to 8.83% in 2025.
  • Per Business Quant, the three most recent readings for MED's FCF Margin are 8.83% (Q4 2025), 12.02% (Q3 2025), and 4.51% (Q2 2025).